X4 Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.19

+0.12 (+2.95%)

As of May 9, 1:54 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +578.3% upside

Low Target $21.41

Average Target $28.42

High Target $38.37

Current Price $4.19

Current
$4.19

Target
$28.42

$21.41 $28.42 avg $38.37

Scenario Analysis

Bear Case

$21.41

411.0%

Low target

Base Case

$28.42

+578.3%

Avg target

Bull Case

$38.37

+815.8%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$4.83

-13.3% from high

52-Week Low

$1.35

+210.4% from low

Target vs 52W High

$28.42

+488.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%